Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity
- 1 August 2010
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 225 (1-2) , 43-51
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/AktJournal of Neuroinflammation, 2008
- Microglia repetitively isolated from in vitro mixed glial cultures retain their initial phenotypeJournal of Neuroscience Methods, 2007
- Cellular and Molecular Mechanisms of Parkinson’s Disease: Neurotoxins, Causative Genes, and Inflammatory CytokinesCellular and Molecular Neurobiology, 2006
- Dopaminergic neurotoxins require excitotoxic stimulation in organotypic culturesNeurobiology of Disease, 2005
- Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neuronsJournal of Neural Transmission, 2004
- RETRACTED: GDNF regulates the Aβ-induced endoplasmic reticulum stress response in rabbit hippocampus by inhibiting the activation of gadd 153 and the JNK and ERK kinasesNeurobiology of Disease, 2004
- Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neuronsJournal of Neural Transmission, 2004
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003
- Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β, and nitric oxideDevelopmental Brain Research, 2002
- Glial Cell Line-derived Neurotrophic Factor Induces Ret-mediated Lamellipodia FormationJournal of Biological Chemistry, 1997